Research Article

Determination of Polar Compounds in Guava Leaves Infusions and Ultrasound Aqueous Extract by HPLC-ESI-MS

Table 2

Quantification (mean ± SD, n = 3) of the compounds identified in guava leaves infusions and ultrasound aqueous extract.

NumberCompoundsQuantification (μg analyte/g leaves)
AEI3I5I7

1HHDP glucose isomer1146 ± 34c2256 ± 37a2253 ± 27a2021 ± 67b
2HHDP glucose isomer228 ± 40b441 ± 72a368 ± 59a,b397 ± 93a,b
3HHDP glucose isomer1424 ± 48c1756 ± 39a1762 ± 12a1546 ± 27b
4Gallic acid719 ± 33a240 ± 5b260 ± 5b254 ± 9b
5Prodelphinidin B2 isomer665 ± 55a212 ± 11b220 ± 12b126 ± 8c
6Pedunculagin/casuariin isomer2405 ± 38a573 ± 14c688 ± 5b533 ± 6c
7Prodelphinidin dimer isomer1768 ± 90a444 ± 26b467 ± 20b335 ± 11b
8Gallocatechin5887 ± 273a2419 ± 19b2301 ± 43b,c1960 ± 77c
9Prodelphinidin dimer isomer5452 ± 308a1526 ± 4b1688 ± 40b1309 ± 34b
10Geraniin isomer1396 ± 47a304 ± 1b318 ± 12b201 ± 8c
11Pedunculagin/casuariin isomer2894 ± 46a687 ± 9c814 ± 19b624 ± 6c
12Geraniin isomer2333 ± 160a433 ± 26b457 ± 8b304 ± 3b
13Procyanidin B isomer17659 ± 785a6703 ± 124b7106 ± 51b6105 ± 34b
14Procyanidin B isomer1751 ± 150a398 ± 10b413 ± 10b321 ± 9b
15Tellimagrandin I isomer 728 ± 26a141 ± 2c184 ± 5b129 ± 2c
16Catechin12875 ± 705a6127 ± 80b5960 ± 19b5192 ± 2b
17Casuarinin/casuarictin isomer8725 ± 216a482 ± 1c859 ± 21b590 ± 17b,c
18Tellimagrandin I isomer 1492 ± 46a186 ± 6b,c243 ± 9b164 ± 3c
19Gallocatechin5866 ± 362a2205 ± 134b,c2446 ± 21b1896 ± 13c
20Myricetin-arabinoside/xylopyranoside isomer608 ± 18a<LOQ<LOQ<LOQ
21Procyanidin B isomer 21206 ± 56a207 ± 14b,c224 ± 7b136 ± 6c
22Myricetin hexoside isomer1301 ± 44a<LOQ<LOQ<LOQ
23Myricetin hexoside isomer331 ± 2a245 ± 2c299 ± 3b232 ± 4d
24Myricetin-arabinoside/xylopyranoside isomer639 ± 29a<LOQ<LOQ<LOQ
25Quercetin-galloylhexoside isomer566 ± 20a148.3 ± 0.1b171 ± 2b149 ± 1b
26Quercetin-galloylhexoside isomer452 ± 15a97.25 ± 0.02b102.3 ± 0.4b 92.25 ± 0.07b
27Myricetin-arabinoside/xylopyranoside isomer592 ± 24a<LOQ<LOQ<LOQ
28Morin8377 ± 464a3235 ± 53b,c3676 ± 12b3003 ± 18c
29Myricetin-arabinoside/xylopyranoside isomer986 ± 28a<LOQ<LOQ<LOQ
30Ellagic acid4338 ± 234a1082 ± 16b1367 ± 14b1040 ± 9b
31Hyperin7798 ± 280a2492 ± 6c2891 ± 7b2031 ± 18d
32Quercetin glucuronide2293 ± 91a1249 ± 19c1612 ± 40b1132 ± 7c
33Isoquercitrin4408 ± 182a1111 ± 19b,c1306 ± 5b996 ± 3c
34Reynoutrin5849 ± 173a1386 ± 21b,c1611 ± 20b1229 ± 9c
35Guajaverin12843 ± 421a3169 ± 40b,c3595 ± 4b2713 ± 36c
36Guavinoside A1920 ± 40a453 ± 3c522 ± 1b413 ± 2c
37Avicularin13666 ± 421a3825 ± 48b4183 ± 34b3232 ± 25c
38Quercitrin 6822 ± 274a1825 ± 39b2078 ± 24b1705 ± 12b
39Guavinoside C2298 ± 40a<LOQ<LOQ<LOQ
40Guavinoside B1456 ± 34a370 ± 3c423 ± 4b328.6 ± 0.1c
41Guavinoside A isomer558 ± 4a177 ± 1b160 ± 4c140.0 ± 0.3d
42Prodelphinidin B2 isomer 2<LOQ<LOQ<LOQ<LOQ
43Guavinoside B isomer<LOQ<LOQ<LOQ<LOQ
44Guavinoside B isomer<LOQndndnd
45Guavinoside B isomer<LOQndndnd
46Guavin B460 ± 6a34 ± 1b32.2 ± 0.2b20 ± 1c
47Quercetin408 ± 18andndnd
48Naringenin538 ± 14c941 ± 3a815 ± 24b558 ± 9c

n.d.: not detected; AE: aqueous extract obtained by ultrasound; I3, I5, and I7: infusion obtained at 3, 5, and 7 minutes of infusion time, respectively.
The different letter in the same line means that the compounds are significantly different (P ≤ 0.05).